These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20430978)

  • 21. Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE epsilon4 carriers.
    Filippini N; Zarei M; Beckmann CF; Galluzzi S; Borsci G; Testa C; Bonetti M; Beltramello A; Ghidoni R; Benussi L; Binetti G; Frisoni GB
    J Magn Reson Imaging; 2009 May; 29(5):1021-6. PubMed ID: 19388128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.
    Darreh-Shori T; Brimijoin S; Kadir A; Almkvist O; Nordberg A
    Neurobiol Dis; 2006 Nov; 24(2):326-33. PubMed ID: 16973370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
    Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease.
    Tröster AI; Fields JA; Paolo AM; Koller WC
    J Neurol Sci; 2006 Oct; 248(1-2):62-7. PubMed ID: 16769085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein epsilon4 allele is associated with psoriasis severity.
    Coto-Segura P; Coto E; Alvarez V; Morales B; Soto-Sánchez J; Corao AI; Santos-Juanes J
    Arch Dermatol Res; 2010 Mar; 302(2):145-9. PubMed ID: 19911187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E epsilon4 allele and lorazepam effects on memory in high-functioning older adults.
    Pomara N; Willoughby L; Wesnes K; Greenblatt DJ; Sidtis JJ
    Arch Gen Psychiatry; 2005 Feb; 62(2):209-16. PubMed ID: 15699298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurovascular coupling in Alzheimer patients: effect of acetylcholine-esterase inhibitors.
    Rosengarten B; Paulsen S; Burr O; Kaps M
    Neurobiol Aging; 2009 Dec; 30(12):1918-23. PubMed ID: 18395940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities.
    Høgh P; Garde E; Mortensen EL; Jørgensen OS; Krabbe K; Waldemar G
    Acta Neurol Scand; 2007 Apr; 115(4):248-53. PubMed ID: 17376122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E modulates auditory event-related potentials in healthy aging.
    Espeseth T; Rootwelt H; Reinvang I
    Neurosci Lett; 2009 Aug; 459(2):91-5. PubMed ID: 19409447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study.
    Huang W; Qiu C; von Strauss E; Winblad B; Fratiglioni L
    Arch Neurol; 2004 Dec; 61(12):1930-4. PubMed ID: 15596614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of cerebral hemodynamic dysregulation in middle-aged APOE ε4 carriers: The PREVENT-Dementia study.
    Dounavi ME; Low A; McKiernan EF; Mak E; Muniz-Terrera G; Ritchie K; Ritchie CW; Su L; O'Brien JT
    J Cereb Blood Flow Metab; 2021 Nov; 41(11):2844-2855. PubMed ID: 34078163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal event-related potentials in young and middle-aged adults with the ApoE ε4 allele.
    Corby K; Morgan CD; Murphy C
    Int J Psychophysiol; 2012 Mar; 83(3):276-81. PubMed ID: 22100309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation-flow coupling differentiates between vascular and Alzheimer type of dementia.
    Rosengarten B; Paulsen S; Molnar S; Kaschel R; Gallhofer B; Kaps M
    J Neurol Sci; 2007 Jun; 257(1-2):149-54. PubMed ID: 17321550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele.
    Suri S; Mackay CE; Kelly ME; Germuska M; Tunbridge EM; Frisoni GB; Matthews PM; Ebmeier KP; Bulte DP; Filippini N
    Alzheimers Dement; 2015 Jun; 11(6):648-57.e1. PubMed ID: 25160043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.